Results 101 to 110 of about 5,819 (177)

Complete pathological response of hormone receptor positive invasive breast cancer in a patient with multiple myeloma treated with ixazomib. [PDF]

Tumori, 2023
Dameri M, Garlaschi A, Cuccarolo P, Ceccardi A, Stabile M, Valente I, Gristina L, Calabrese M, Ballestrero A, Tagliafico A, Zoppoli G.   +10 more
europepmc   +1 more source

Editorial: Risk factors in multiple myeloma identified before and during treatment: are we ready to personalize treatment? [PDF]

Front Oncol, 2023
D'Agostino M, Terragna C, van Duin M.
europepmc   +1 more source

Correction to: Continous or fixed carfilzomib, lenalidomide and dexamethasone (KRD) for relapsed-refractory multiple myeloma: long-term follow-up from a multicenter, retrospective real-life survey from European myeloma network (EMN) Italy : Correction to: annals of hematology. [PDF]

Ann Hematol
Conticello C, Del Fabro V, Romano A, Mele A, Mina R, Bringhen S, Orofino A, Antonioli E, Pulini S, De Paoli L, Za T, Cotzia E, Elia F, Casson A, Prete E, Citiso S, Liberatore C, Margiotta-Casaluci G, Fazio F, Morè S, Attucci I, Accardi F, Bongarzoni V, Mangiacavalli S, Rossi E, Mannina D, Garibaldi B, Rizzi R, Di Cecca M, Rossini B, Uccello G, Botta C, Leotta D, Vincelli D, Gentile M, Piciocchi A, Marsili G, Patriarca F, Zambello R, Musto P, Boccadoro M, Offidani M, Petrucci MT, Di Raimondo F.   +43 more
europepmc   +1 more source

Simvastatin Protects Osteoblasts from the Deleterious Effects of the Liquid Milieu of Multiple Myeloma. [PDF]

West Indian Med J, 2015
Jitumori R, Fernandes D, Jitumori C, Favero GM.   +3 more
europepmc   +1 more source

Adverse outcome associated with daratumumab-based treatments in relapsed/refractory multiple myeloma patients with amplification of chromosome arm 1q21: a single-center retrospective experience. [PDF]

Ann Hematol, 2022
Barbieri E, Maccaferri M, Leonardi G, Giacobbi F, Corradini G, Lagreca I, Barozzi P, Potenza L, Marasca R, Luppi M.   +9 more
europepmc   +1 more source

Hip Hemiarthroplasty in Patients with Multiple Myeloma: A Retrospective Case Series and Review of the Literature. [PDF]

Rev Bras Ortop (Sao Paulo)
Mahmoud AN, Ordas-Bayon A, Doyle CM, Echeverry-Martinez MF, Horwitz DS.   +4 more
europepmc   +1 more source

Multiple Myeloma (Part 1) - Update on Epidemiology, Diagnostic Criteria, Systemic Treatment and Prognosis. [PDF]

Rev Bras Ortop (Sao Paulo), 2023
Guedes A, Becker RG, Teixeira LEM.
europepmc   +1 more source

Ten-year experience on home care for patients with plasma cell disorders: bringing optimal therapy home. [PDF]

Clin Exp Med
Bigi F, Fiacchini M, Restuccia R, Masci S, Mazzocchetti G, Talarico M, Puppi M, Sacchetti I, Manzato E, Iezza M, Mancuso K, Sartor C, Pantani L, Tacchetti P, Alatif RA, Pastore E, Barbato S, Cavo M, Zamagni E, Rizzello I.   +19 more
europepmc   +1 more source

Transplante de progenitores hematopoyéticos (TPH) alogénico no mieloablativo [PDF]

El objetivo de este trabajo es investigar la toxicidad y demostrar la factibilidad y eficacia del injerto hematopoyético proveniente de un donante emparentado HLA-idéntico tras un acondicionamiento no mieloablativo en pacientes con enfermedades ...
Ballester, Carmen, Bautista, Antonia Maria, Besalduch Vidal, Juan, Canaro, Mariana, Gutiérrez, Antonio, Sampol, Antònia   +5 more
core